Cipla prices Favipiravir at Rs 68 per tablet; RIL breaks more records

Mukesh Ambani-led Reliance Industries Ltd (RIL) recorded the highest value of transactions for a share ever on NSE yesterday; The legal profession, like many other sectors, will see disruptive change with 20 per cent of the routine legal works likely to be automated in the future, predicts a survey conducted by BML Munjal University (BMU); Cipla on Friday said that it has received the Drug Controller General of India (DCGI) approval for the launch of experimental coronavirus drug Favipiravir in India for treatment of COVID-19 patients. Watch this and more on News Blast.

Also Read: Coronavirus vaccine news update: Human trials underway for Indian vaccines in 6 cities